Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma
Clinical trial NCT00210353 · COMPLETED
Trial details
- NCT number
- NCT00210353
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2015-04-01
- Enrollment
- 454
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.